Primary hepatic large B-cell lymphoma following direct-acting antiviral treatment for hepatitis C
Hepatitis C virus (HCV) infection is a major public health concern worldwide, raising important medical and economic issues. HCV-related end-stage liver disease is one of the most common indications for hepatic transplantation. Chronic hepatitis C is also assimilated to a systemic disease because of...
Saved in:
| Main Authors: | Yosra Zaimi, Myriam Ayari, Walid Cherifi, Feryel Letaief Ksontini, Shema Ayadi, Emna Bel Hadj Mabrouk, Myriam Jrad |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMJ Publishing Group
2021-10-01
|
| Series: | BMJ Open Gastroenterology |
| Online Access: | https://bmjopengastro.bmj.com/content/8/1/e000721.full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Direct Acting Antivirals for the Treatment of Chronic Viral Hepatitis
by: Peter Karayiannis
Published: (2012-01-01) -
Direct Acting Antivirals in Patients with Chronic Hepatitis C and Down Syndrome
by: Eric R. Yoo, et al.
Published: (2016-01-01) -
Pancreatic Metastasis of Renal Cell Carcinoma: A Surgical Indication for a Disseminated Disease
by: Feryel Letaief Ksontini, et al.
Published: (2021-01-01) -
Self-reported experience in patients treated with Hepatitis C direct acting antivirals
by: Irene Cañamares Orbis, et al.
Published: (2016-12-01) -
Medicaid and Medicare Utilization of Direct-Acting Antiviral Medications for Patients With Hepatitis C
by: Xiaohan Ying, et al.
Published: (2025-01-01)